ROSEN, NATIONAL TRIAL LAWYERS, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

NEW YORK, Dec. 2, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between March 10, 2021 and October 4, 2022, both dates inclusive (the "Class Period"), of the important...